Health Benefits
Equilib Capsules
Supplement Facts - Equilib Capsules
Equilib Orange Drink Mix
Supplement Facts - Equilib Orange Drink Mix
Research Results
FAQ
Want to maintain mental and emotional health?
Equilib™ is a 100% natural dietary supplement designed to provide nutritional support for individuals concerned with maintaining their mental and emotional well-being.*
In preliminary clinical and open-label studies, the pre-cursor product to Equilib™ showed early promise in delivering many important health benefits. The second phase of research, now underway, appears to confirm these product attributes.
Health Benefits
Price: $68.98 USD per bottle – 56 servings
Dosage Instructions: The dosage is dependent upon the customer’s age and response to the Nutrient Program, contact your Research Assistant. Consult with a physician prior to use if you have any serious health concerns.
Contra-indications: There are no known side effects from Equilib*trade;; however, pregnant or lactating women, diabetics, hypoglycemics, and people with known medical conditions should consult with a physician before taking the product.

Equilib™ is a unique combination of vitamins, minerals and plant nutrients designed to provide nutritional support for the central nervous system.* It is available in two forms - in regular capsule form and a powder drink mix.
Price: $44.95 per canister - 25 servings
Product Development: The powdered drink was developed with Dr Nayan Shah who received his Ph.D. in Food Science from Rutgers University. He has over 30 years of food and supplement industry experience in product development, nutrition, regulatory, and quality assurance. The Equilib™ Orange Drink Mix uses the same high quality ingredients as the Equilib™ apsules and, using Dr Shah’s extensive experience with flavor profiles, we have developed a powdered drink that tastes good and is a convenient enjoyable way to give nutritional support for the central nervous system.
Usage Instructions: The Equilib™ Powder, Orange Drink Mix is designed for use by individual’s who are under 12 years of age, are capsule intolerant, or prefer variety in their daily regimen. The cost efficiency of the powder is best achieved if used in combination with capsules. We suggest the powder be used in the mornings or evenings and capsules during mid-morning or afternoon.
Contra-indications: There are no known side effects from Equilib™ however, pregnant or lactating women, diabetics, hypoglycemics, and people with known medical conditions should consult with a physician before taking the product.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

The Evince International Research Group is currently in the second phase of a three phase research program. The current study is designed to confirm the hypothesis that:
"nutriceutical intervention can be an effective first step in the treatment hierarchy for patients with CNS imbalances".
Four peer-reviewed open-label and clinical research studies provide initial results supporting this hypothesis. Click on the link below to view the most recent research abstract.
Effective Mood Stabilization With a Chelated Mineral Supplement: An Open-Label Trial in Bipolar Disorder - Bonnie J. Kaplan, Ph.D.(Research psychologist, University of Calgary)*
The research protocol has been designed to determine the optimum usage level for each CNS condition, determine which CNS conditions can be ameliorated by nutriceutical intervention, determine the effectiveness on each category (A-D) of participant (based on severity of symptoms), and assess all positive and negative long-term side effects – including drug/nutrient interactions where applicable.
We require a significant number of research participants to fully populate the study. Eight CNS conditions and three age categories will be studied. When all cells are fully populated, additional participants will not be added to the program.
This peer reviewed article, along with with a research commentary, can be read in its entirety by registering at The Journal of Clinical Psychiatry website at www.psychiatrist.com. Here are the steps to take to register and read full text content:
Please see our FAQ page